-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Izokibep in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Izokibep in Hidradenitis Suppurativa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Izokibep in Hidradenitis Suppurativa Drug Details: Izokibep (ABY-035) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Izokibep in Intermediate Uveitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Izokibep in Intermediate Uveitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Izokibep in Intermediate Uveitis Drug Details: Izokibep (ABY-035) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Izokibep in Psoriatic Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Izokibep in Psoriatic Arthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Izokibep in Psoriatic Arthritis Drug Details: Izokibep (ABY-035) is under development...
-
Sector Analysis
NewNorth America Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2024 Update
North America Destination Tourism Report Overview In 2023, international arrivals to the region reached 126.7 million, which is still lower than the pre-pandemic level seen in 2019. The numbers are however expected to surpass the pre-pandemic levels in 2024. As per GlobalData, the number of international arrivals will grow at a CAGR of more than 8% from 2023 to 2028, helped by the region’s reputation for attractive and varied landscapes, wildlife, sun and beach destinations, modern cities, and appeal for...
-
Sector Analysis
NewSouth Korea Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
South Korea Source Tourism Report Overview The total outbound trips from South Korea during 2023 reached 23.17 million, which was still around 80% of 2019 numbers. This trend is largely attributed to the reopening of the borders and relaxation of travel measures. International travel recovery from South Korea has been stable and is expected to grow, with numbers indicating that it will surpass pre-pandemic levels by the end of 2024. The South Korean tourism market is going to rely heavily...
-
Product Insights
NewAffibody AB Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Affibody AB Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs. It discovers and develops drugs based on its proprietary technology platforms such as Albumod and Affibody molecules. Its Affibody molecules are a class of antibody mimetics that surpass monoclonal antibodies and antibody fragments. Affibody’s Albumod technology is designed to enhance the efficacy of...
-
Sector Analysis
Italy Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
Italy Source Tourism Report Overview The total outbound trips in Italy surpassed pre-pandemic levels, increasing to 35.22 million in 2023. The strong desire to travel and experience new things post the easing of pandemic-related travel restrictions; the reduction in travel costs by low-cost airlines; and the growing disposable incomes of younger passengers are contributing to this development. The projected compound annual growth rate (CAGR) for international departures is more than 6% for 2023-2027. The Italy source tourism market research report...
-
Product Insights
Shanghai Surpass-Golmud Solar PV Park
Shanghai Surpass-Golmud Solar PV Park is a solar PV project located in China. The project is owned and developed by Shanghai Surpass Sun Electric Co.,Ltd. The project came online in 2013. Empower your strategies with our Shanghai Surpass-Golmud Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Product Insights
Shanghai Surpass-Baike Delhi Solar PV Park
Shanghai Surpass-Baike Delhi Solar PV Park is a solar PV project located in China. The project is owned and developed by Shanghai Surpass Sun Electric Co.,Ltd. The project came online in 2013. Empower your strategies with our Shanghai Surpass-Baike Delhi Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....